Ding Sheng, Schultz Peter G
Department of Chemistry and the Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA.
Nat Biotechnol. 2004 Jul;22(7):833-40. doi: 10.1038/nbt987.
Although stem cells hold considerable promise for the treatment of numerous diseases including cardiovascular disease, neurodegenerative disease, musculoskeletal disease, diabetes and cancer, obstacles such as the control of stem cell fate, allogenic rejection and limited cell availability must be overcome before their therapeutic potential can be realized. This requires an improved understanding of the signaling pathways that affect stem cell fate. Cell-based phenotypic and pathway-specific screens of natural products and synthetic compounds have recently provided a number of small molecules that can be used to selectively control stem cell proliferation and differentiation. Examples include the selective induction of neurogenesis and cardiomyogenesis in murine embryonic stem cells, osteogenesis in mesenchymal stem cells and dedifferentiation in skeletal muscle cells. Such molecules will likely provide new insights into stem cell biology, and may ultimately contribute to effective medicines for tissue repair and regeneration.
尽管干细胞在治疗包括心血管疾病、神经退行性疾病、肌肉骨骼疾病、糖尿病和癌症在内的多种疾病方面具有巨大潜力,但在实现其治疗潜力之前,必须克服诸如干细胞命运控制、同种异体排斥和细胞可用性有限等障碍。这需要更好地理解影响干细胞命运的信号通路。最近,基于细胞的天然产物和合成化合物的表型和通路特异性筛选提供了许多可用于选择性控制干细胞增殖和分化的小分子。例子包括在小鼠胚胎干细胞中选择性诱导神经发生和心肌发生、在间充质干细胞中诱导成骨以及在骨骼肌细胞中诱导去分化。这些分子可能会为干细胞生物学提供新的见解,并最终可能有助于开发用于组织修复和再生的有效药物。